With the analysis among 1,021 patents, we discovered top 275 key players by total patent application. Immatics Biotechnologies GmbH, Idera Pharmaceuticals, Inc., Enlivex Therapeutics Ltd. are dominant in this area. They take 20.37% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 143
Idera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 40
Enlivex Therapeutics Ltd.
New Jersey, United States
Patent: 24
Utah, United States
Patent: 23
California, United States
Patent: 20
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 16
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 14
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 13
With the analysis among 70 patents, we discovered top 14 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, NantOmics LLC, Targimmune Therapeutics AG are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 20
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 8
Massachusetts, United States
Patent: 3
California, United States
Patent: 2
California, United States
Patent: 1
Utah, United States
Patent: 1
With the analysis among related 479 patents applied in the last 5 years. We discover 179 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Vor Biopharma, Inc., Nant Holdings IP LLC take 22.34% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 81
Massachusetts, United States
Patent: 16
California, United States
Patent: 10
Enlivex Therapeutics Ltd.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 10
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 9
California, United States
Patent: 9
Regents of the University of California
California, United States
Patent: 8
The Board of Regents of The University of Texas System
Texas, United States
Patent: 8
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 8
With the analysis among related 479 patents in last 5 years, we discover 122 new entrants. Vor Biopharma, Inc., Targimmune Therapeutics AG, Philips are the most active new entrants in this area.
Massachusetts, United States
Patent: 16
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 8
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 7
Zeria Pharmaceutical Co., Ltd.
Texas, United States
Patent: 5
California, United States
Patent: 4
Hyogo College of Medicine
With the analysis among 371 patents, we discovered top 71 universities and scientific research institutions by total patent application. The Johns Hopkins University, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon are dominant in this area. They take 15.90% of the total patent filing.
The Johns Hopkins University
Université Claude Bernard Lyon 1
École Normale Supérieure de Lyon
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 10
University of Southern California
California, United States
Patent: 8
The University of Chicago
Illinois, United States
Patent: 8
The Rockefeller University
New York, United States
Patent: 8
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 5
Baylor College of Medicine
Texas, United States
Patent: 5